N4 Pharma Webinar on SRI Collaboration
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your THAT notes
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, will provide a pre-recorded webinar relating to the Company's recent Collaboration Agreement with SRI International Inc. which was announced on 25 April 2024.
The webinar will be available for viewing on 7 May 2024 at 10:00 BST, via the Company's Investor Hub: investors.n4pharma.com/welcome.
Investors will be notified via email of the presentation if they have signed up to the N4 Pharma Investor Hub in advance, which can be done here: investors.n4pharma.com/auth/signup.
Investors are invited to submit questions in advance via N4 Pharma's Investor Hub, and CEO Nigel Theobald will address as many as possible. Register and submit questions at: investors.n4pharma.com
| InvestorHub Engage with us directly at N4 Pharma Investor Hub | Sign up at investors.n4pharma.com https://investors.n4pharma.com/link/4PKgJP |
About N4 Pharma
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.